From left to right: Thomas Schmidt, co-founder and CEO at 21st.BIO, Margrethe Vestager, Executive Vice President of the European Commia hundred other guests from the financial, political, and bio industrial sectors.ssion, and Per Falholt, co-founder and CSO at 21st.BIO, unveiled 21st.BIO’s pilot plant facility. © 21st.BIO A/S

Danish CDMO 21st.BIO A/S has unveiled a new pilot plant facility to accelerate scaling of biotech processes ranging from food and beverages, agriculture, biomaterials, and biopharma.
  

  

16-9-BioFlo320-BioBLU

Single-use bioreactor technology offers a set of benefits compared to common glass or stainless-steel vessels, including reduced downtime between runs, minimal cleaning effort, or decreased cross-contamination risk. In that regard, BioBLU® Single-Use Bioreactors combine the benefits of single-use bioreactor technology with the reliable performance of conventional glass or stainless-steel bioreactors. Furthermore, using them together with a powerful bioprocess controller like the BioFlo® 320 enables precise cell culture parameter control and seamless process transition to up to 40 L of working volume.

© German cancer research centre/ University Heidelberg

Flagging of CAR-T cells with the B7H6 protein weakened the response to human leukaemia in models as it marks them for NK cell attack, German researchers report.

Platform of Biotalys. © Biotalys BV

Belgian AgTech specialist Biotalys BV an Agricultural Technology (AgTech) company has initiated field trials for BioFun-6, the company’s second llama-antibody-mimicking biofungicide program.

CROLA-Champion-Expertise-2024_91_.jpg

Global contract research organization honored as top outsourcing partner, earning high marks in several categories from Industry Standard Research.

Picture: Calluna Pharma

Oslo-based Calluna Pharma appoints Margrethe Sørgaard as Senior Vice President of Clinical Operations and Pharmacovigilance.

Fundus of patient with teinitis pigmentosa. © By Christian Hamel - wikimedia.org

AI specialist WhiteLab Genomics, the Vision Institute, and IT expert ADLIN Science, have entered into a strategic partnership aimed at developing new AAV vectors targetting retinal dystrophies.

© University of Southern Denmark

A German-Danish team has discovered that a truncated version of the enzyme adenlyate cyclase 3 can be targeted to transform fat-storing white adipocytes into fat-burning brown adipocytes.

Picture: Genomtec S.A.

Dr Trevor Hawkins, entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Polish molecular diagnostic company Genomtec S.A.

Klineo team has grown since its inception in 2021. © Kineo SAS

Paris-based Klineo SAS has raised €2M to speed up access to clinical trials for oncology patients using an AI platform.
`